National Cancer Centre Singapore (NCCS) shared a post on LinkedIn:
“The Asia Pacific Hepatocellular Carcinoma Trials Group (AHCC), led by Professor Pierce Chow, is recruiting liver cancer patients who have undergone surgery for the EMPHASIS clinical trial. The goal is to determine which group of patients responds best to a combination therapy of atezolizumab + bevacizumab and deliver more precise and personalised treatment of the Asian-prevalent disease.”
More posts featuring Liver Cancer on OncoDaily.
